http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102367746-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70c3cd9dccf7b8f1ea8151f2c3dd9591 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-0244 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2207-10 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-0015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C33-3878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C33-3857 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29C33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29C33-38 |
filingDate | 2021-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b4e3bf0d19c65c611600be0950877c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a354f51b4f6eada4cfeab25fc5ab84b |
publicationDate | 2022-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102367746-B1 |
titleOfInvention | Method of manufacturing micro needle transdermal drug patch and ultrasonic delivery device thereof |
abstract | The present invention injects (administers) a microneedle in which a drug (medicament, drug) and a biodegradable polymer are mixed into the body through the patient's skin, but reduces the skin opening time by rapidly injecting (administrating) the open skin. It relates to a method for manufacturing a transdermal drug patch microneedle and an ultrasonic injection device that can be manufactured by arbitrarily selecting the amount and duration for which the drug is absorbed into the human body while preventing infection and discharging body fluids and drugs. A hydrogel base layer having a thickness of 1 to 1.5 millimeters and being flexible; A microneedle layer in which one or more conical microneedles, in which a biodegradable polymer and a chemical are mixed, are arranged on one plane of the hydrogel base layer at uniform intervals in front, back, left and right; It is adhered closely to the other side of the hydrogel base layer, is flexible, and includes a piezoelectric film layer that generates an ultrasonic signal of 20 to 1,000 megahertz by the application of operating power. The microneedle is manufactured as a drug for the treatment of drugs, so that the penetration of the drug into the skin is fast and the skin opening time for drug injection is reduced so that the human body is not infected, the body fluids and drugs are not discharged out of the skin, and the time for the absorption of the drug into the body is long. There is an effect of manufacturing a microneedle that can be selectively controlled, and reducing the skin injection time of the microneedle. |
priorityDate | 2021-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.